01635oam 2200445I 450 991070400960332120151112155555.0(CKB)5470000002437563(OCoLC)846903715(EXLCZ)99547000000243756320130606d2013 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierThe effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /Luke M. Olson, Brett W. WendlingWashington, DC :Bureau of Economics, Federal Trade Commission,2013.1 online resource (41 unnumbered pages) illustrationsWorking paper ;no. 317Title from title screen (viewed on June 6, 2013)."April 2013."Includes bibliographical references.Generic drugsEconomic aspectsUnited StatesGeneric drugsPricesUnited StatesDrugsPricesUnited StatesGeneric drugsEconomic aspectsGeneric drugsPricesDrugsPricesOlson Luke M.1420553Wendling Brett W.United States.Federal Trade Commission.Bureau of Economics,AZSAZSOCLCQGPOBOOK9910704009603321The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period3538877UNINA